Sign Up Now!
To sign up for our newsletter or print publications, please enter your contact information below and click "Subscribe".
First Name
*
Last Name
*
Email Address
*
Email Address (Verify)
*
TOP Print Edition
We will request your mailing address on the next page.
JHOP/TOP E-Newsletters & Communications
I have reviewed and consent to the terms of
TOP
's
Privacy Policy
, and
TOP
has my permission to retain my information in its database, and to forward pertinent communications to me.
Home
Issues
2019
November 2019 - Vol 12 No 4
August 2019 - Vol 12 No 3
May 2019 - Vol 12 No 2
February 2019 - Vol 12 No 1
2018
November 2018 - Vol 11 No 3
August 2018 - Vol 11 No 2
May 2018 - Vol 11 No 1
Issue Archive
Special Issues
Supplements
Guide to New FDA Approvals
2019 Fourth Annual Guide
2018 Third Annual Guide
2017 Second Annual Guide
2016 First Annual Guide
Categories
Conference Correspondent
Web Exclusives
Ovarian Cancer Overview
All Web Exclusives
Drug Updates
FDA Approvals, News & Updates
In the News
Press Releases
Online First
Media Library
Videos
Audiocasts
Quick Quiz
CE
About
About TOP
Advertise
Editorial Board
Contact Us
Resources
Submit
Author Guidelines
Leslie Lauersdorf, ARNP
Moffitt Cancer Center
Tampa Bay, Florida
Authored Items
Keeping Up to Date on New Multiple Myeloma Drugs
Leslie Lauersdorf, ARNP
Conference Correspondent
in
Hematologic Cancers
,
Conference Correspondent
,
ASH
Caring for Patients with Relapsed/Refractory Multiple Myeloma
Leslie Lauersdorf, ARNP
Conference Correspondent
in
Hematologic Cancers
,
Conference Correspondent
,
ASH
Educating Your Patients About Daratumumab
Leslie Lauersdorf, ARNP
Conference Correspondent
in
Hematologic Cancers
,
Conference Correspondent
,
ASH
Patient Education is Crucial
Leslie Lauersdorf, ARNP
Conference Correspondent
in
Hematologic Cancers
,
Conference Correspondent
,
ASH
How Patients Can Help with Side Effect Management
Leslie Lauersdorf, ARNP
Conference Correspondent
in
Hematologic Cancers
,
Conference Correspondent
,
ASH
New Therapies to Treat Multiple Myeloma
Leslie Lauersdorf, ARNP
Conference Correspondent
in
Hematologic Cancers
,
Conference Correspondent
,
ASH
The Importance of Survivorsihp Care in Mutliple Myeloma
Leslie Lauersdorf, ARNP
Conference Correspondent
in
Hematologic Cancers
,
Conference Correspondent
,
ASH
A Look at Daratumumab
Leslie Lauersdorf, ARNP
Conference Correspondent
in
Conference Correspondent
,
ASH
Daratumumab: What Patients Want to Know
Leslie Lauersdorf, ARNP
Conference Correspondent
in
Conference Correspondent
,
ASH
Managing Treatment-Related Toxicities
Leslie Lauersdorf, ARNP
Conference Correspondent
in
Conference Correspondent
,
ASH
The Janssen CarePath Program and the Cost of Care
Leslie Lauersdorf, ARNP
Conference Correspondent
in
Conference Correspondent
,
ASH
Last modified: December 4, 2016
Home
Issues
2019
November 2019 - Vol 12 No 4
August 2019 - Vol 12 No 3
May 2019 - Vol 12 No 2
February 2019 - Vol 12 No 1
2018
November 2018 - Vol 11 No 3
August 2018 - Vol 11 No 2
May 2018 - Vol 11 No 1
Issue Archive
Special Issues
Supplements
Guide to New FDA Approvals
2019 Fourth Annual Guide
2018 Third Annual Guide
2017 Second Annual Guide
2016 First Annual Guide
Categories
Conference Correspondent
Web Exclusives
Ovarian Cancer Overview
All Web Exclusives
Drug Updates
FDA Approvals, News & Updates
In the News
Press Releases
Online First
Media Library
Videos
Audiocasts
Quick Quiz
CE
About
About TOP
Advertise
Editorial Board
Contact Us
Resources
Submit
Author Guidelines